The United States’ ongoing transformation of federal cannabis policy—from rigid Schedule I prohibition under the Controlled Substances Act (CSA) to a more nuanced regulatory framework—has long been cabined by claims of international legal constraint. For decades, the Drug Enforcement Administration (DEA) invoked the 1961 Single Convention on Narcotic Drugs as an absolute bar to any … Continue reading Why Business Lawyers and Lawmakers Must Master the U.S. Reinterpretation of the Single Convention: Treaty Flexibility as the Foundation for Durable Cannabis Reform